GYN 15

Cards (147)

  • Abnormal uterine bleeding (AUB)

    Any uterine bleeding outside the normal volume, duration, regularity or frequency
  • Nearly 30% of all gynecological outpatient attendants are for AUB
  • Normal menstruation
    • Cycle interval: 28 days (21–35 days)
    • Menstrual flow: 4–5 days
    • Menstrual blood loss: 35 mL (20–80 mL)
  • PALM-COEIN
    Acronym that subdivides all the causes of AUB into nine main categories
  • PALM categories
    • Polyp
    • Adenomyosis
    • Leiomyoma
    • Malignancy and hyperplasia
  • COEIN categories
    • Coagulopathy
    • Ovulatory dysfunction
    • Endometrial
    • Iatrogenic
    • Not yet identified
  • AUB notation
    AUB is followed by the letters PALM–COEIN and a subscript 0 or 1 associated with each letter to indicate the absence or presence in respect of the abnormality
  • AUB examples
    • AUB: P0A1L0M0–C0O0E0I0N0
    • P1A0L0M0–C0O1E0I0N0
  • Leiomyoma category
    Subdivided into patients with at least one submucosal myoma (LSM) and those with myomas that do not affect the endometrial cavity (L0)
  • Menorrhagia
    Cyclic bleeding at normal intervals that is either excessive in amount (> 80 mL) or duration (>7 days) or both
  • Organic causes of menorrhagia
    • Pelvic: Fibroid uterus, adenomyosis, pelvic endometriosis, IUCD in utero, chronic tubo-ovarian mass, tubercular endometritis, retroverted uterus, granulosa cell tumor of the ovary
    • Systemic: Liver dysfunction, congestive cardiac failure, severe hypertension
    • Endocrinal: Hypothyroidism, hyperthyroidism
    • Hematological: Idiopathic thrombocytopenic purpura, leukemia
  • Functional causes of menorrhagia are due to disturbed hypothalamo-pituitary-ovarian-endometrial axis
  • Diagnosis of menorrhagia
    Long duration of flow, passage of big clots, use of increased number of thick sanitary pads, pallor, and low level of hemoglobin
  • Polymenorrhea
    Cyclic bleeding where the cycle is reduced to an arbitrary limit of less than 21 days and remains constant at that frequency
  • Epimenorrhagia
    Polymenorrhea associated with excessive and/or prolonged bleeding
  • Causes of polymenorrhea
    • Dysfunctional: Seen during adolescence, preceding menopause, following delivery and abortion
    • Ovarian hyperemia: Pelvic inflammatory disease, ovarian endometriosis
  • Metrorrhagia
    Irregular, acyclic bleeding from the uterus with variable amount of bleeding
  • Causes of contact bleeding
    • Carcinoma cervix, mucus polyp of cervix, vascular ectopy of the cervix, infections, cervical endometriosis
  • Causes of acyclic bleeding
    • DUB, submucous fibroid, uterine polyp, carcinoma cervix and endometrial carcinoma
  • Menometrorrhagia
    Irregular and excessive bleeding where the menses (periods) cannot be identified at all
  • Causes of oligomenorrhea
    • Age-related, weight-related, stress and exercise related, endocrine disorders, androgen producing tumors, tubercular endometritis, drugs
  • Hypomenorrhea
    Menstrual bleeding that is unduly scanty and lasts for less than 2 days
  • Dysfunctional uterine bleeding (DUB)

    Abnormal uterine bleeding without any clinically detectable organic, systemic, and iatrogenic cause
  • Heavy menstrual bleeding (HMB) is defined as a bleeding that interferes with woman's physical, emotional, social and maternal quality of life
  • DUB is currently defined as a state of abnormal uterine bleeding following anovulation due to dysfunction of hypothalamo-pituitary-ovarian axis
  • Structural causes of abnormal bleeding
    • Uterine: Leiomyoma, adenomyosis, endometrial hyperplasia or malignancy, arteriovenous malformation
    • Cervix: Polyp, cancer
    • Vagina: Cancer
    • Fallopian tube: Cancer
  • Nonstructural systemic causes of abnormal bleeding
    • Ovarian tumors, anovulation, thyroid dysfunction, hyperprolactinemia, androgen excess, premature ovarian failure
    • Pregnancy complications: Miscarriages, gestational trophoblastic disease
    • Iatrogenic: Medications, IUCD, trauma
    • Infections: STIs, endometritis, tuberculosis
    • Systemic: Hepatic and renal dysfunction, coagulopathies
  • Endometrial polyps (AUB-P)

    • Diagnosis is made by sonography. MRI is superior to USG.
  • Adenomyosis (AUB-A)

    • Diagnosis is made by sonography. MRI is superior to USG.
  • Leiomyoma (AUB-L)
    • Classification system includes submucosal, intramural and subserosal fibroids.
  • Malignancy (AUB-M)

    • Includes female genital tract cancers. Malignancy is observed in 4.5% of postmenopausal women when they present with symptoms.
  • Coagulopathy (AUB-C)

    • Includes von Willebrand disease, prothrombin deficiency, hemophilias A, B, ITP, leukemia, platelet deficiency, inherited coagulopathies due to deficiency of other clotting factors.
  • Anticoagulation therapy
    • Women on heparin or LMWH may present with AUB. Nearly 20% of adolescent girls with AUB have been found to suffer from coagulation disorders.
  • Ovulatory dysfunction (AUB-O)

    • Often seen in the premenarchal and premenopausal women due to abnormality of neuroendocrine function and anovulation.
  • Iatrogenic (AUB-I)

    • Mostly due to medications like breakthrough bleeding following the use of combined oral contraceptives, erratic use of pills or any contraceptive steroids, use of IUCDs, or LNG-IUS.
  • Endometrial (AUB-E)
    • Abnormal endometrial production of PGI2 and deficiency of PGF2a or excessive production of PGE, chronic inflammatory changes.
  • Not otherwise specified (AUB-N)
    Includes trauma and foreign bodies
  • Diagnostic criteria to detect coagulopathy
    • One of the following: PPH, surgical bleed, dental bleed
    • Two of the following: Bruising >5 cm, epistaxis 1–2 episodes/month, gum bleeding, family history of bleeding
  • Treatment is directed to the underlying pathology and malignancy is to be excluded prior to any definitive treatment
  • Oligomenorrhea
    Menstrual bleeding occurring more than 35 days apart and which remains constant at that frequency